Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.
The global Pneumococcal Polysaccharide Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pneumococcal Polysaccharide Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Polysaccharide Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Merck & Co., Inc.
Pfizer Inc.
Glaxosmithkline Plc.
Sanofi Pasteur
China National Biotec Group
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Single Dose Vial
Pre-Filled Syringe
Segment by Application
Children (2-10 Age)
Adult (10-64 Age)
Geriatric (More Than 65 Age)
Table of Contents Executive Summary 1 Pneumococcal Polysaccharide Vaccine Market Overview 1.1 Product Overview and Scope of Pneumococcal Polysaccharide Vaccine 1.2 Pneumococcal Polysaccharide Vaccine Segment by Type1.2.1 Global Pneumococcal Polysaccharide Vaccine Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Single Dose Vial 1.2.3 Pre-Filled Syringe 1.3 Pneumococcal Polysaccharide Vaccine Segment by Application1.3.1 Pneumococcal Polysaccharide Vaccine Consumption Comparison by Application (2014-2025) 1.3.2 Children (2-10 Age) 1.3.3 Adult (10-64 Age) 1.3.4 Geriatric (More Than 65 Age) 1.4 Global Pneumococcal Polysaccharide Vaccine Market by Region1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Pneumococcal Polysaccharide Vaccine Market Size1.5.1 Global Pneumococcal Polysaccharide Vaccine Revenue (2014-2025) 1.5.2 Global Pneumococcal Polysaccharide Vaccine Production (2014-2025) 2 Global Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers 2.1 Global Pneumococcal Polysaccharide Vaccine Production Market Share by Manufacturers (2014-2019) 2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2014-2019) 2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Pneumococcal Polysaccharide Vaccine Production Sites, Area Served, Product Types 2.5 Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends2.5.1 Pneumococcal Polysaccharide Vaccine Market Concentration Rate 2.5.2 Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Pneumococcal Polysaccharide Vaccine Production Market Share by Regions 3.1 Global Pneumococcal Polysaccharide Vaccine Production Market Share by Regions 3.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions (2014-2019) 3.3 Global Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Pneumococcal Polysaccharide Vaccine Production3.4.1 North America Pneumococcal Polysaccharide Vaccine Production Growth Rate (2014-2019) 3.4.2 North America Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Pneumococcal Polysaccharide Vaccine Production3.5.1 Europe Pneumococcal Polysaccharide Vaccine Production Growth Rate (2014-2019) 3.5.2 Europe Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 3.6 China Pneumococcal Polysaccharide Vaccine Production (2014-2019)3.6.1 China Pneumococcal Polysaccharide Vaccine Production Growth Rate (2014-2019) 3.6.2 China Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 3.7 Japan Pneumococcal Polysaccharide Vaccine Production (2014-2019)3.7.1 Japan Pneumococcal Polysaccharide Vaccine Production Growth Rate (2014-2019) 3.7.2 Japan Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Pneumococcal Polysaccharide Vaccine Consumption by Regions 4.1 Global Pneumococcal Polysaccharide Vaccine Consumption by Regions 4.2 North America Pneumococcal Polysaccharide Vaccine Consumption (2014-2019) 4.3 Europe Pneumococcal Polysaccharide Vaccine Consumption (2014-2019) 4.4 China Pneumococcal Polysaccharide Vaccine Consumption (2014-2019) 4.5 Japan Pneumococcal Polysaccharide Vaccine Consumption (2014-2019) 5 Global Pneumococcal Polysaccharide Vaccine Production, Revenue, Price Trend by Type 5.1 Global Pneumococcal Polysaccharide Vaccine Production Market Share by Type (2014-2019) 5.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2014-2019) 5.3 Global Pneumococcal Polysaccharide Vaccine Price by Type (2014-2019) 5.4 Global Pneumococcal Polysaccharide Vaccine Production Growth by Type (2014-2019) 6 Global Pneumococcal Polysaccharide Vaccine Market Analysis by Applications 6.1 Global Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2014-2019) 6.2 Global Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Pneumococcal Polysaccharide Vaccine Business 7.1 Merck & Co., Inc.7.1.1 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.1.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.1.4 Main Business and Markets Served 7.2 Pfizer Inc.7.2.1 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.2.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.2.4 Main Business and Markets Served 7.3 Glaxosmithkline Plc.7.3.1 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.3.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.3.4 Main Business and Markets Served 7.4 Sanofi Pasteur7.4.1 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.4.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.4.4 Main Business and Markets Served 7.5 China National Biotec Group7.5.1 China National Biotec Group Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.5.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.5.4 Main Business and Markets Served 7.6 Astellas Pharma Inc7.6.1 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.6.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.6.4 Main Business and Markets Served 7.7 Serum Institute of India Pvt. Ltd7.7.1 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Production Sites and Area Served 7.7.2 Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification 7.7.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Production, Revenue, Price and Gross Margin (2014-2019) 7.7.4 Main Business and Markets Served 8 Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis 8.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine 8.4 Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.2 Pneumococcal Polysaccharide Vaccine Distributors List 9.3 Pneumococcal Polysaccharide Vaccine Customers 10 Market Dynamics 10.1 Market Trends 10.2 Opportunities 10.3 Market Drivers 10.4 Challenges 10.5 Influence Factors 11 Global Pneumococcal Polysaccharide Vaccine Market Forecast 11.1 Global Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast11.1.1 Global Pneumococcal Polysaccharide Vaccine Production Growth Rate Forecast (2019-2025) 11.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2019-2025) 11.1.3 Global Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2019-2025) 11.2 Global Pneumococcal Polysaccharide Vaccine Production Forecast by Regions (2019-2025)11.2.1 North America Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2019-2025) 11.2.2 Europe Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2019-2025) 11.2.3 China Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2019-2025) 11.2.4 Japan Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2019-2025) 11.3 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast by Regions (2019-2025)11.3.1 North America Pneumococcal Polysaccharide Vaccine Consumption Forecast (2019-2025) 11.3.2 Europe Pneumococcal Polysaccharide Vaccine Consumption Forecast (2019-2025) 11.3.3 China Pneumococcal Polysaccharide Vaccine Consumption Forecast (2019-2025) 11.3.4 Japan Pneumococcal Polysaccharide Vaccine Consumption Forecast (2019-2025) 11.4 Global Pneumococcal Polysaccharide Vaccine Production, Revenue and Price Forecast by Type (2019-2025) 11.5 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List
Summary: Get latest Market Research Reports on Pneumococcal Polysaccharide Vaccine. Industry analysis & Market Report on Pneumococcal Polysaccharide Vaccine is a syndicated market report, published as Global Pneumococcal Polysaccharide Vaccine Market Research Report 2019. It is complete Research Study and Industry Analysis of Pneumococcal Polysaccharide Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 12 March, 2019